Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 23677175)

1.

Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma.

Remke M, Hering E, Gerber NU, Kool M, Sturm D, Rickert CH, Gerß J, Schulz S, Hielscher T, Hasselblatt M, Jeibmann A, Hans V, Ramaswamy V, Taylor MD, Pietsch T, Rutkowski S, Korshunov A, Monoranu CM, Frühwald MC.

Childs Nerv Syst. 2013 Aug;29(8):1253-62. doi: 10.1007/s00381-013-2142-4. Epub 2013 May 16.

PMID:
23677175
2.

High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy.

Frühwald MC, O'Dorisio MS, Pietsch T, Reubi JC.

Pediatr Res. 1999 May;45(5 Pt 1):697-708.

PMID:
10231868
3.

MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.

Grotzer MA, Hogarty MD, Janss AJ, Liu X, Zhao H, Eggert A, Sutton LN, Rorke LB, Brodeur GM, Phillips PC.

Clin Cancer Res. 2001 Aug;7(8):2425-33.

4.

Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.

Phi JH, Kim JH, Eun KM, Wang KC, Park KH, Choi SA, Kim YY, Park SH, Cho BK, Kim SK.

J Neurosurg Pediatr. 2010 Jun;5(6):608-14. doi: 10.3171/2010.2.PEDS1065.

PMID:
20515335
5.

[Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor].

Chang Q, Ng HK.

Zhonghua Bing Li Xue Za Zhi. 2007 Jan;36(1):24-8. Chinese.

PMID:
17374234
6.

Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma.

Faoro D, von Bueren AO, Shalaby T, Sciuscio D, Hürlimann ML, Arnold L, Gerber NU, Haybaeck J, Mittelbronn M, Rutkowski S, Hegi M, Grotzer MA.

J Neurooncol. 2011 May;103(1):59-69. doi: 10.1007/s11060-010-0366-7. Epub 2010 Sep 5.

PMID:
20820873
7.

Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.

Eberhart CG, Kratz J, Wang Y, Summers K, Stearns D, Cohen K, Dang CV, Burger PC.

J Neuropathol Exp Neurol. 2004 May;63(5):441-9.

PMID:
15198123
8.

Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.

Grotzer MA, Janss AJ, Phillips PC, Trojanowski JQ.

Klin Padiatr. 2000 Jul-Aug;212(4):196-9.

PMID:
10994550
9.

Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment.

Liang Y, Diehn M, Bollen AW, Israel MA, Gupta N.

J Neurooncol. 2008 Jan;86(2):133-41. Epub 2007 Jul 25.

PMID:
17653508
10.

Differential expression of somatostatin receptors, P44/42 MAPK, and mTOR activation in medulloblastomas and primitive neuroectodermal tumors.

Johnson MD, O'Connell MJ, Silberstein H, Korones D.

Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):532-8. doi: 10.1097/PAI.0b013e3182813724.

PMID:
23455179
11.

Differential expression of somatostatin receptors in ependymoma: implications for diagnosis.

Guyotat J, Champier J, Jouvet A, Signorelli F, Houzard C, Bret P, Saint Pierre G, Fevre Montange M.

Int J Cancer. 2001 May 20;95(3):144-51.

PMID:
11307146
12.

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.

Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, Cho YJ, Koster J, Schouten-van Meeteren A, van Vuurden D, Clifford SC, Pietsch T, von Bueren AO, Rutkowski S, McCabe M, Collins VP, Bäcklund ML, Haberler C, Bourdeaut F, Delattre O, Doz F, Ellison DW, Gilbertson RJ, Pomeroy SL, Taylor MD, Lichter P, Pfister SM.

Acta Neuropathol. 2012 Apr;123(4):473-84. doi: 10.1007/s00401-012-0958-8. Epub 2012 Feb 23.

13.

Rapid diagnosis of medulloblastoma molecular subgroups.

Schwalbe EC, Lindsey JC, Straughton D, Hogg TL, Cole M, Megahed H, Ryan SL, Lusher ME, Taylor MD, Gilbertson RJ, Ellison DW, Bailey S, Clifford SC.

Clin Cancer Res. 2011 Apr 1;17(7):1883-94. doi: 10.1158/1078-0432.CCR-10-2210. Epub 2011 Feb 16.

14.

Somatostatin receptor gene expression in neuroblastoma.

Albers AR, O'Dorisio MS, Balster DA, Caprara M, Gosh P, Chen F, Hoeger C, Rivier J, Wenger GD, O'Dorisio TM, Qualman SJ.

Regul Pept. 2000 Mar 17;88(1-3):61-73.

PMID:
10706954
15.

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples.

Northcott PA, Shih DJ, Remke M, Cho YJ, Kool M, Hawkins C, Eberhart CG, Dubuc A, Guettouche T, Cardentey Y, Bouffet E, Pomeroy SL, Marra M, Malkin D, Rutka JT, Korshunov A, Pfister S, Taylor MD.

Acta Neuropathol. 2012 Apr;123(4):615-26. doi: 10.1007/s00401-011-0899-7. Epub 2011 Nov 6.

16.

Differential expression of somatostatin receptors in medulloblastoma.

Guyotat J, Champier J, Pierre GS, Jouvet A, Bret P, Brisson C, Belin MF, Signorelli F, Montange MF.

J Neurooncol. 2001 Jan;51(2):93-103.

PMID:
11386415
17.

c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.

von Bueren AO, Oehler C, Shalaby T, von Hoff K, Pruschy M, Seifert B, Gerber NU, Warmuth-Metz M, Stearns D, Eberhart CG, Kortmann RD, Rutkowski S, Grotzer MA.

BMC Cancer. 2011 Feb 16;11:74. doi: 10.1186/1471-2407-11-74.

18.

[Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].

Frühwald MC, O'Dorisio MS, Smith L, Dai Z, Wright FA, Paulus W, Jürgens H, Plass C.

Klin Padiatr. 2001 Jul-Aug;213(4):197-203. German.

PMID:
11528554
19.

Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.

Marchetti D, Mrak RE, Paulsen DD, Sinnappah-Kang ND.

J Exp Clin Cancer Res. 2007 Mar;26(1):5-23.

PMID:
17550129
20.

Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor.

Fouladi M, Gajjar A, Boyett JM, Walter AW, Thompson SJ, Merchant TE, Jenkins JJ, Langston JW, Liu A, Kun LE, Heideman RL.

J Clin Oncol. 1999 Oct;17(10):3234-7.

PMID:
10506624
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk